Folate-conjugates and corresponding metal-chelate complexes for use in diagnostic imaging and radiotherapy

Details for Australian Patent Application No. 2008237935 (hide)

Owner Merck Eprova AG

Inventors Mindt, Thomas Leighton; Schibli, Roger; Muller, Cristina Magdalena; Michel, Urs; Sparr, Christoph; Groehn, Viola; Moser, Rudolf

Agent Davies Collison Cave

Pub. Number AU-A-2008237935

PCT Pub. Number WO2008/125618

Priority 07105980.2 11.04.07 EP

Filing date 11 April 2008

Wipo publication date 23 October 2008

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 51/02 (2006.01) Preparations containing radioactive substances for use in therapy or testing - characterised by the carrier

Event Publications

29 October 2009 PCT application entered the National Phase

  PCT publication WO2008/125618 Priority application(s): WO2008/125618

8 December 2011 Alteration of Name

  The name of the applicant has been altered to Merck & Cie

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008237940-Molecules and methods for modulating proprotein convertase subtilisin/kexin type 9 (PCSK9)

2008237934-18F-labelled folates